Bicycle Therapeutics Net Worth

Bicycle Therapeutics Net Worth Breakdown

  BCYC
The net worth of Bicycle Therapeutics is the difference between its total assets and liabilities. Bicycle Therapeutics' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Bicycle Therapeutics' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Bicycle Therapeutics' net worth can be used as a measure of its financial health and stability which can help investors to decide if Bicycle Therapeutics is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Bicycle Therapeutics stock.

Bicycle Therapeutics Net Worth Analysis

Bicycle Therapeutics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Bicycle Therapeutics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Bicycle Therapeutics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Bicycle Therapeutics' net worth analysis. One common approach is to calculate Bicycle Therapeutics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Bicycle Therapeutics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Bicycle Therapeutics' net worth. This approach calculates the present value of Bicycle Therapeutics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Bicycle Therapeutics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Bicycle Therapeutics' net worth. This involves comparing Bicycle Therapeutics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Bicycle Therapeutics' net worth relative to its peers.
To determine if Bicycle Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Bicycle Therapeutics' net worth research are outlined below:
Bicycle Therapeutics generated a negative expected return over the last 90 days
Bicycle Therapeutics has high historical volatility and very poor performance
The company reported the previous year's revenue of 35.27 M. Net Loss for the year was (169.03 M) with loss before overhead, payroll, taxes, and interest of (137.69 M).
Bicycle Therapeutics currently holds about 372.77 M in cash with (164.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 92.0% of the company shares are held by institutions such as insurance companies
Bicycle Therapeutics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Bicycle Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bicycle Therapeutics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow Bicycle Therapeutics' market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 662.27 M.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bicycle Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bicycle Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bicycle Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Travis Thompson over two weeks ago
Acquisition by Travis Thompson of 43500 shares of Bicycle Therapeutics at 14.0 subject to Rule 16b-3
 
Lee Kevin over two months ago
Disposition of 9038 shares by Lee Kevin of Bicycle Therapeutics at 14.09 subject to Rule 16b-3
 
Baker Bros. Advisors Lp over two months ago
Acquisition by Baker Bros. Advisors Lp of 8801 shares of Bicycle Therapeutics at 14.0 subject to Rule 16b-3
 
Sands Stephen H. over two months ago
Insider Trading
 
Baker Bros. Advisors Lp over three months ago
Acquisition by Baker Bros. Advisors Lp of 42369 shares of Bicycle Therapeutics at 15.3418 subject to Rule 16b-3
 
Travis Thompson over three months ago
Disposition of 1109 shares by Travis Thompson of Bicycle Therapeutics at 9.82 subject to Rule 16b-3
 
Travis Thompson over three months ago
Disposition of 154 shares by Travis Thompson of Bicycle Therapeutics at 8.21 subject to Rule 16b-3
 
Travis Thompson over three months ago
Disposition of 153 shares by Travis Thompson of Bicycle Therapeutics at 22.26 subject to Rule 16b-3
 
Nicholas Keen over three months ago
Acquisition by Nicholas Keen of 28000 shares of Bicycle Therapeutics subject to Rule 16b-3
 
Travis Thompson over three months ago
Disposition of 153 shares by Travis Thompson of Bicycle Therapeutics at 22.26 subject to Rule 16b-3
 
Arroyo Santiago over six months ago
Acquisition by Arroyo Santiago of 120000 shares of Bicycle Therapeutics at 21.77 subject to Rule 16b-3
 
Skynner Michael over six months ago
Disposition of 967 shares by Skynner Michael of Bicycle Therapeutics at 19.64 subject to Rule 16b-3
Bicycle Therapeutics time-series forecasting models is one of many Bicycle Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bicycle Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bicycle Therapeutics Earnings per Share Projection vs Actual

Bicycle Therapeutics Corporate Management

Kevin MBACEO DirectorProfile
CBE FMedsciNonEx CoFounderProfile
Christian HeinisScientific FounderProfile
Stephanie YaoSenior CommunicationsProfile
Alistair MilnesChief OfficerProfile
Gillian LangfordHead ManagementProfile
When determining whether Bicycle Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bicycle Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bicycle Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bicycle Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.